Association Between Baseline, Achieved, and Reduction of CRP and Cardiovascular Outcomes After LDL Cholesterol Lowering with Statins or Ezetimibe: A Systematic Review and Meta‐Analysis

BACKGROUND: Several lipid‐lowering therapies reduce CRP (C‐reactive protein) independently of LDL‐C (low‐density lipoprotein cholesterol) reduction, but the association between CRP parameters and benefits from more‐intensive LDL‐C lowering is inconclusive. We aimed to determine whether the benefits...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xin‐Lin, Lan, Rong‐Fang, Zhang, Xiao‐Wen, Xu, Wei, Wang, Lian, Kang, Li‐Na, Xu, Biao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Systematic Review and Meta‐analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6759897/
https://www.ncbi.nlm.nih.gov/pubmed/31411090
http://dx.doi.org/10.1161/JAHA.119.012428

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6759897/
https://www.ncbi.nlm.nih.gov/pubmed/31411090
http://dx.doi.org/10.1161/JAHA.119.012428

Ejemplares similares